The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer
- PMID: 37164172
- DOI: 10.1016/j.critrevonc.2023.104020
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer
Abstract
Pancreatic cancer has an incidence that almost matches its mortality. Only a small number of risk factors and 33 susceptibility loci have been identified. so Moreover, the relative rarity of pancreatic cancer poses significant hurdles for research aimed at increasing our knowledge of the genetic mechanisms contributing to the disease. Additionally, the inability to adequately power research questions prevents small monocentric studies from being successful. Several consortia have been established to pursue a better understanding of the genetic architecture of pancreatic cancers. The Pancreatic disease research (PANDoRA) consortium is the largest in Europe. PANDoRA is spread across 12 European countries, Brazil and Japan, bringing together 29 basic and clinical research groups. In the last ten years, PANDoRA has contributed to the discovery of 25 susceptibility loci, a feat that will be instrumental in stratifying the population by risk and optimizing preventive strategies.
Keywords: Chronic pancreatitis; Consortium; Genetic epidemiology; Intraductal papillary mucinous neoplasms; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pancreatic neuroendocrine tumors.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest MFB has received research funding from Celgene, Frame Therapeutics, and Lead Pharma, and has acted as a consultant to Servier.
Similar articles
-
Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.Cancer Epidemiol Biomarkers Prev. 2022 May 4;31(5):942-948. doi: 10.1158/1055-9965.EPI-21-1340. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35506247 Free PMC article.
-
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.Int J Cancer. 2018 Jan 15;142(2):290-296. doi: 10.1002/ijc.31047. Epub 2017 Oct 16. Int J Cancer. 2018. PMID: 28913878
-
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.Oncol Rep. 2013 Apr;29(4):1637-44. doi: 10.3892/or.2013.2285. Epub 2013 Feb 12. Oncol Rep. 2013. PMID: 23403949
-
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.United European Gastroenterol J. 2021 Sep;9(7):860-871. doi: 10.1002/ueg2.12123. Epub 2021 Aug 25. United European Gastroenterol J. 2021. PMID: 34431604 Free PMC article. Review.
-
Germline genetic variability in pancreatic cancer risk and prognosis.Semin Cancer Biol. 2022 Feb;79:105-131. doi: 10.1016/j.semcancer.2020.08.003. Epub 2020 Aug 18. Semin Cancer Biol. 2022. PMID: 32818625 Review.
Cited by
-
The 12-Year Experience of the Hungarian Pancreatic Study Group.J Clin Med. 2025 Feb 18;14(4):1362. doi: 10.3390/jcm14041362. J Clin Med. 2025. PMID: 40004893 Free PMC article. Review.
-
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study.Sci Rep. 2024 Oct 24;14(1):25144. doi: 10.1038/s41598-024-77431-5. Sci Rep. 2024. PMID: 39448785 Free PMC article.
-
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.Int J Cancer. 2025 Jan 15;156(2):339-352. doi: 10.1002/ijc.35196. Epub 2024 Sep 25. Int J Cancer. 2025. PMID: 39319538 Free PMC article.
-
The future of collaborative precision oncology approaches in sub-Saharan Africa: learnings from around the globe.Front Oncol. 2024 Jun 21;14:1426558. doi: 10.3389/fonc.2024.1426558. eCollection 2024. Front Oncol. 2024. PMID: 38974239 Free PMC article.
-
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.Biol Res. 2023 Aug 13;56(1):46. doi: 10.1186/s40659-023-00457-y. Biol Res. 2023. PMID: 37574541 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical